{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:16:20Z","timestamp":1777504580661,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.peptides.2022.170858","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:13:11Z","timestamp":1659525191000},"page":"170858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3"],"prefix":"10.1016","volume":"156","author":[{"given":"Terry W.","family":"Moody","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Ramos-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2022.170858_bib1","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1158\/1078-0432.CCR-10-0659","article-title":"Neurotensin receptor 1 determines the outcome of non-small cell lung cancer","volume":"16","author":"Alifano","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.peptides.2022.170858_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0196-9781(88)90224-0","article-title":"Neurotensin binds with high affinity to small cell lung cancer cells","volume":"9","author":"Allen","year":"1988","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2022.170858_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.onc.1209814","article-title":"Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src\/Stat 5b pathway","volume":"26","author":"Amorino","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.peptides.2022.170858_bib4","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1016\/S0021-9258(19)43429-7","article-title":"The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalamus","volume":"248","author":"Carraway","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2022.170858_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbamcr.2012.11.021","article-title":"Gastrointestinal hormones simulate growth of foregut neuroendocrine tumors by transactivating the EGF receptor","volume":"1833","author":"Di Florio","year":"2013","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.peptides.2022.170858_bib6","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.18632\/oncotarget.1632","article-title":"Activation of EGFR, HER2 and HER3 by neurotensin\/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice","volume":"5","author":"Dupouy","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.peptides.2022.170858_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1006\/bbrc.2000.2335","article-title":"Neurotensin-mediated activation of the MAPK pathways and AP-1 binding in the human pancreatic cancer cell line MIA PaCa-2","volume":"269","author":"Ehlers","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2022.170858_bib8","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.peptides.2006.01.028","article-title":"Neurotensin and growth of normal and neoplastic tissues","volume":"27","author":"Evers","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2022.170858_bib9","first-page":"1632","article-title":"Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1","volume":"62","author":"Guha","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.peptides.2022.170858_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.regpep.2004.03.004","article-title":"Involvement of MAP kinase, PI-3-kinase and EGF-receptor in the stimulatory effect of neurotensin on DNA synthesis in PC3 cells","volume":"120","author":"Hassan","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2022.170858_bib11","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1158\/0008-5472.CAN-15-1010","article-title":"Non-small cell lung cancer cells acquire resistance to the ALK inhibitor alectinib by activating alternative receptor tyrosine kinases","volume":"76","author":"Isozaki","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.peptides.2022.170858_bib12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/JTO.0000000000000544","article-title":"Fusion gene is a novel oncogenic driver of non-small-cell lung adenocarcinoma","volume":"10","author":"Jung","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.peptides.2022.170858_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40259-016-0205-2","article-title":"HER3 as a therapeutic target in cancer","volume":"31","author":"Karachallou","year":"2017","journal-title":"Biodrugs"},{"key":"10.1016\/j.peptides.2022.170858_bib14","series-title":"Cancer: Principles and Practice of Oncology","first-page":"789","article-title":"Molecular biology of lung cancer","author":"Kaufman","year":"2011"},{"key":"10.1016\/j.peptides.2022.170858_bib15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/jcp.20187","article-title":"Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling to ductal pancreatic cancer cells","volume":"202","author":"Kisfalvi","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.peptides.2022.170858_bib16","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.peptides.2006.02.013","article-title":"Functional domains of the subtype 1 neurotensin receptor (NTS1)","volume":"27","author":"Kitabgi","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2022.170858_bib17","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.annonc.2020.08.2335","article-title":"NRG1 fushion-driven tumors: Biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents","author":"Laskin","year":"2020","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.peptides.2022.170858_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.118625","article-title":"Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism","volume":"67","author":"Lee","year":"2020","journal-title":"Biochem. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.peptides.2022.170858_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020768","article-title":"The EGFR family: not so prototypical receptor tyrosine kinase","volume":"6","author":"Lemmon","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"355","key":"10.1016\/j.peptides.2022.170858_bib20","first-page":"45","article-title":"HER3 signaling and targeted therapy in cancer","volume":"12","author":"Mishra","year":"2018","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.peptides.2022.170858_bib21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/0024-3205(85)90555-7","article-title":"Neurotensin is produced and secreted by classic small cell lung cancer cells","volume":"36","author":"Moody","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.peptides.2022.170858_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lfs.2014.01.072","article-title":"SR48692 inhibits non-small cell lung cancer proliferation in an EGFR receptor-dependent manner","volume":"100","author":"Moody","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.peptides.2022.170858_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0196-9781(00)00362-4","article-title":"SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells","volume":"22","author":"Moody","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2022.170858_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172735","article-title":"Neurotensin receptors regulate transactivation of the EGFR and Her2 in a reactive oxygen species-dependent manner","volume":"865","author":"Moody","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2022.170858_bib25","first-page":"9,345","article-title":"Neuropeptide G protein-coupled receptors as oncotargets","author":"Moody","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.peptides.2022.170858_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170480","article-title":"Bombesin, endothelin, neurotensin and pituitary adenylate cyclase activating polypeptide cause tyrosine phosphorylation of receptor tyrosine kinases","volume":"137","author":"Moody","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2022.170858_bib27","doi-asserted-by":"crossref","first-page":"89284","DOI":"10.18632\/oncotarget.18467","article-title":"A comprehensive review of heregulins, HER3 and HER4 as potential therapeutic targets in cancer","volume":"8","author":"Mota","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.peptides.2022.170858_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2407-11-421","article-title":"Role of protein kinase C and epidermal growth factor receptor signaling in growth stimulation by neurotensin in colon carcinoma cells","volume":"11","author":"Muller","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.peptides.2022.170858_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(00)00248-8","article-title":"Use of RT-PCR to detect expression of neuropeptides and their receptors in lung cancer","volume":"33","author":"Ocejo-Garci","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.peptides.2022.170858_bib30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1183\/09031936.00.16599100","article-title":"Ploidy, expression of erbB1, ErbB2, p53 and amplification of erbB1, erbB2 and erbB3 in non- small cell lung cancer","volume":"16","author":"Reinmuth","year":"2000","journal-title":"Eur. J. Respir. J."},{"key":"10.1016\/j.peptides.2022.170858_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2014.06.001","article-title":"ErbB\/HER protein-tyrosine kinases: structures and small molecule inhibitors","volume":"87","author":"Roskoski","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.peptides.2022.170858_bib32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1634\/theoncologist.2018-0695","article-title":"Randomized phase II trial of seribantumab in combination with erlotinib in patient with EGFR wild-type non-small cell lung cancer","author":"Sequist","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.peptides.2022.170858_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00280-016-3231-3","article-title":"Phase 1 study of new formulation of patritumab (U3-1287) process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancer","volume":"79","author":"Shimizu","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.peptides.2022.170858_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/cgt.2008.15","article-title":"The ERBB3 receptor in cancer and gene therapy","volume":"15","author":"Sithanandam","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.peptides.2022.170858_bib35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/carcin\/bgi269","article-title":"Neurotensin receptor 1 gene activation by the Tcf\/\u03b2-catenin pathway is an early event in human colonic adenomas","volume":"27","author":"Souaze","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.peptides.2022.170858_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0196-9781(89)90015-6","article-title":"Neurotensin elevates cytosolic calcium in small cell lung cancer cells","volume":"10","author":"Staley","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2022.170858_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung Cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2022.170858_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-7219-7_1","article-title":"ErbB receptors and cancer","volume":"1652","author":"Wang","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.peptides.2022.170858_bib39","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1210\/jcem-53-6-1310","article-title":"Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma","volume":"53","author":"Wood","year":"1981","journal-title":"J. Clin. Endocrinol."},{"key":"10.1016\/j.peptides.2022.170858_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2018.12.007","article-title":"Modulation of lung cancer cell plasticity and heterogeneity with restoration of cisplatin sensitivity by neurotensin antibody","volume":"444","author":"Wu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.peptides.2022.170858_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2016.11.032","article-title":"Neurotensin regulation induces overexpression and activation of EGFR in HCC and restores response to erlotinib and sorafenib","volume":"388","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.peptides.2022.170858_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc3309","article-title":"The ERBB network: at last, cancer therapy meets system biology","volume":"12","author":"Yarden","year":"2012","journal-title":"Nat. Rev. \/Cancer"},{"key":"10.1016\/j.peptides.2022.170858_bib43","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.18632\/oncotarget.1633","article-title":"Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine\/paracrine activation in lung tumors, confirming responsiveness to erlotinib","volume":"5","author":"Younes","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.peptides.2022.170858_bib44","doi-asserted-by":"crossref","first-page":"C1397","DOI":"10.1152\/ajpcell.00328.2002","article-title":"Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways","volume":"284","author":"Zhao","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.peptides.2022.170858_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13000-015-0410-1","article-title":"The significance of NTR1 expression and its correlation with \u03b2-catenin and EGFR in gastric cancer","volume":"100","author":"Zhou","year":"2015","journal-title":"Diagn. Pathol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978122001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978122001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:32:40Z","timestamp":1759311160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978122001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":45,"alternative-id":["S0196978122001243"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2022.170858","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2022.170858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170858"}}